{
  "actions": [
    {
      "acted_at": "2016-03-17", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-03-17", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2016-03-18", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4784-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "B001257", 
      "district": "12", 
      "name": "Bilirakis, Gus M.", 
      "original_cosponsor": true, 
      "sponsored_at": "2016-03-17", 
      "state": "FL", 
      "thomas_id": "01838", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-03-17", 
  "number": "4784", 
  "official_title": "To increase competition in the pharmaceutical industry.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s2615-114", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Lower Drug Costs through Competition Act", 
  "sponsor": {
    "bioguide_id": "S001180", 
    "district": "5", 
    "name": "Schrader, Kurt", 
    "state": "OR", 
    "thomas_id": "01950", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-03-17", 
  "subjects": [
    "Congressional oversight", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug trafficking and controlled substances", 
    "Government studies and investigations", 
    "Health", 
    "Infectious and parasitic diseases", 
    "Licensing and registrations", 
    "Prescription drugs", 
    "User charges and fees"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Lower Drug Costs through Competition Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To increase competition in the pharmaceutical industry.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Lower Drug Costs through Competition Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:28:52Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr4784.xml"
}